Literature DB >> 34362959

Inhibition of CSF1R, a receptor involved in microglia viability, alters behavioral and molecular changes induced by cocaine.

Maria Carolina Machado da Silva1, Giovanni Freitas Gomes1, Heliana de Barros Fernandes2,3, Aristóbolo Mendes da Silva3, Antônio Lúcio Teixeira4, Fabrício A Moreira5, Aline Silva de Miranda2, Antônio Carlos Pinheiro de Oliveira6.   

Abstract

Different data suggest that microglia may participate in the drug addiction process as these cells respond to neurochemical changes induced by the administration of these substances. In order to study the role of microglia in drug abuse, Swiss mice aged 8-9 weeks were treated with the CSF1R inhibitor PLX3397 (40 mg/kg, p.o.) and submitted to behavioral sensitization or conditioned place preference (CPP) induced by cocaine (15 mg/kg, i.p.). Thereafter, brains were used to evaluate the effects of CSF1R inhibition and cocaine administration on morphological, biochemical and molecular changes. CSF1R inhibition attenuated behavioral sensitization, reduced the number of Iba-1+ cells and increased ramification and lengths of the branches in the remaining microglia. Additionally, both cocaine and PLX3397 increased the cell body to total cell size ratio of Iba-1+ cells, as well as CD68+ and GFAP+ stained areas, suggesting an activated pattern of the glial cells. Besides, CSF1R inhibition increased CX3CL1 levels in the striatum, prefrontal cortex and hippocampus, as well as reduced CX3CR1 expression in the hippocampus. In this region, cocaine also reduced BDNF levels, an effect that was enhanced by CSF1R inhibition. In summary, our results suggest that microglia participate in the behavioral and molecular changes induced by cocaine. This study contributes to the understanding of the role of microglia in cocaine addiction.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34362959     DOI: 10.1038/s41598-021-95059-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  74 in total

1.  Cocaine conditioning induces persisting changes in ventral hippocampus synaptic transmission, long-term potentiation, and radial arm maze performance in the mouse.

Authors:  Collin J Preston; Kyle A Brown; John J Wagner
Journal:  Neuropharmacology       Date:  2019-03-01       Impact factor: 5.250

2.  Plasticity at Thalamo-amygdala Synapses Regulates Cocaine-Cue Memory Formation and Extinction.

Authors:  Matthew T Rich; Yanhua H Huang; Mary M Torregrossa
Journal:  Cell Rep       Date:  2019-01-22       Impact factor: 9.423

Review 3.  Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse.

Authors:  Michael J Lacagnina; Phillip D Rivera; Staci D Bilbo
Journal:  Neuropsychopharmacology       Date:  2016-07-11       Impact factor: 7.853

Review 4.  Drugs currently in Phase II clinical trials for cocaine addiction.

Authors:  Jee Hyun Kim; Andrew J Lawrence
Journal:  Expert Opin Investig Drugs       Date:  2014-04-29       Impact factor: 6.206

Review 5.  Etiological theories of addiction: A comprehensive update on neurobiological, genetic and behavioural vulnerability.

Authors:  Mounir Ouzir; Mohammed Errami
Journal:  Pharmacol Biochem Behav       Date:  2016-06-12       Impact factor: 3.533

Review 6.  New findings on biological factors predicting addiction relapse vulnerability.

Authors:  Rajita Sinha
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

Review 7.  Multiple faces of BDNF in cocaine addiction.

Authors:  Xuan Li; Marina E Wolf
Journal:  Behav Brain Res       Date:  2014-11-15       Impact factor: 3.332

Review 8.  Neurobiologic Advances from the Brain Disease Model of Addiction.

Authors:  Nora D Volkow; George F Koob; A Thomas McLellan
Journal:  N Engl J Med       Date:  2016-01-28       Impact factor: 91.245

9.  The in Vivo Neurochemical Profile of Selectively Bred High-Responder and Low-Responder Rats Reveals Baseline, Cocaine-Evoked, and Novelty-Evoked Differences in Monoaminergic Systems.

Authors:  Omar S Mabrouk; John L Han; Jenny-Marie T Wong; Huda Akil; Robert T Kennedy; Shelly B Flagel
Journal:  ACS Chem Neurosci       Date:  2017-12-12       Impact factor: 5.780

Review 10.  Novel technologies in detection, treatment and prevention of substance use disorders.

Authors:  Hichem Moulahoum; Figen Zihnioglu; Suna Timur; Hakan Coskunol
Journal:  J Food Drug Anal       Date:  2018-09-28       Impact factor: 6.157

View more
  1 in total

1.  Aberrant expression of BDNF might serve as a candidate target for cocaine-induced psychosis: insights from bioinformatics analysis and microarray validation.

Authors:  Youwei Zhu; Yan Zhao; Xiaomin Xu; Hang Su; Xiaotong Li; Na Zhong; Haifeng Jiang; Jiang Du; Min Zhao
Journal:  Gen Psychiatr       Date:  2021-10-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.